Results 171 to 180 of about 14,731 (198)
Some of the next articles are maybe not open access.
Journal of Vascular and Interventional Radiology, 2021
PURPOSE To evaluate the pathologic outcomes of hepatocellular carcinoma (HCC) treated with Yttrium-90 radiation segmentectomy using glass microspheres prior to liver transplantation and explore parameters associated with pathologic necrosis.
B. Toskich +13 more
semanticscholar +1 more source
PURPOSE To evaluate the pathologic outcomes of hepatocellular carcinoma (HCC) treated with Yttrium-90 radiation segmentectomy using glass microspheres prior to liver transplantation and explore parameters associated with pathologic necrosis.
B. Toskich +13 more
semanticscholar +1 more source
Surgery, 2021
BACKGROUND Portal vein embolization before liver resection is considered the therapy of choice for patients with inadequate future liver remnants. The concept of radioembolization with Yttrium-90 to achieve the same goal has limited data.
Yuki Bekki +11 more
semanticscholar +1 more source
BACKGROUND Portal vein embolization before liver resection is considered the therapy of choice for patients with inadequate future liver remnants. The concept of radioembolization with Yttrium-90 to achieve the same goal has limited data.
Yuki Bekki +11 more
semanticscholar +1 more source
Hepatology, 2020
Radioembolization (yttrium‐90 [Y90]) is used in hepatocellular carcinoma (HCC) as a bridging as well as downstaging liver‐directed therapy to curative liver transplantation (LT). In this study, we report long‐term outcomes of LT for patients with HCC who
A. Gabr +20 more
semanticscholar +1 more source
Radioembolization (yttrium‐90 [Y90]) is used in hepatocellular carcinoma (HCC) as a bridging as well as downstaging liver‐directed therapy to curative liver transplantation (LT). In this study, we report long‐term outcomes of LT for patients with HCC who
A. Gabr +20 more
semanticscholar +1 more source
Journal of Surgical Oncology, 2020
This study assessed the outcomes of Yttrium‐90 (90Y) radiation segmentectomy for hepatic metastases unamenable to resection or ablation.
S. Padia +6 more
semanticscholar +1 more source
This study assessed the outcomes of Yttrium‐90 (90Y) radiation segmentectomy for hepatic metastases unamenable to resection or ablation.
S. Padia +6 more
semanticscholar +1 more source
European Journal of Radiology, 2020
PURPOSE Sarcopenia is associated with adverse outcomes in several gastrointestinal malignancies and liver cirrhosis. We aimed to study the utility of magnetic resonance imaging (MRI) derived fat-free muscle area (FFMA) to predict clinical outcome in ...
A. Faron +9 more
semanticscholar +1 more source
PURPOSE Sarcopenia is associated with adverse outcomes in several gastrointestinal malignancies and liver cirrhosis. We aimed to study the utility of magnetic resonance imaging (MRI) derived fat-free muscle area (FFMA) to predict clinical outcome in ...
A. Faron +9 more
semanticscholar +1 more source
Pediatric Blood & Cancer, 2020
Primary malignant liver tumors are rare but all require surgical resection as part of therapy with curative intent. A minority of patients have resectable tumors at diagnosis.
A. Aguado +6 more
semanticscholar +1 more source
Primary malignant liver tumors are rare but all require surgical resection as part of therapy with curative intent. A minority of patients have resectable tumors at diagnosis.
A. Aguado +6 more
semanticscholar +1 more source
Journal of Vascular and Interventional Radiology, 2019
PURPOSE To investigate the safety of yttrium-90 radioembolization in combination with checkpoint inhibitor immunotherapy for the treatment of hepatocellular carcinoma (HCC).
C. Zhan +9 more
semanticscholar +1 more source
PURPOSE To investigate the safety of yttrium-90 radioembolization in combination with checkpoint inhibitor immunotherapy for the treatment of hepatocellular carcinoma (HCC).
C. Zhan +9 more
semanticscholar +1 more source